TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer
Xiaofeng Dai(Jiangnan University), Jun Deng(Nanchang University)
Cited by 17
Related Papers
Advances and Trends in Omics Technology Development
|Frontiers in Medicine|2022|494
<i>Invivo</i>Pen: A novel plasma source for <i>in vivo</i> cancer treatment
|Journal of Cancer|2020|49
Cold atmospheric plasmas target breast cancer stemness via modulating AQP3-19Y mediated AQP3-5K and FOXO1 K48-ubiquitination
|International Journal of Biological Sciences|2022|48
Genetic interactions between ANLN and KDR are prognostic for breast cancer survival
|Oncology Reports|2019|36